MA27530A1 - Utilisation de la levocetirizine pour le traitement de la rhinite allergique persistante. - Google Patents
Utilisation de la levocetirizine pour le traitement de la rhinite allergique persistante.Info
- Publication number
- MA27530A1 MA27530A1 MA28297A MA28297A MA27530A1 MA 27530 A1 MA27530 A1 MA 27530A1 MA 28297 A MA28297 A MA 28297A MA 28297 A MA28297 A MA 28297A MA 27530 A1 MA27530 A1 MA 27530A1
- Authority
- MA
- Morocco
- Prior art keywords
- levocetirizine
- treatment
- allergic rhinitis
- persistent allergic
- persistent
- Prior art date
Links
- ZKLPARSLTMPFCP-OAQYLSRUSA-N 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid Chemical compound C1CN(CCOCC(=O)O)CCN1[C@@H](C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-OAQYLSRUSA-N 0.000 title abstract 2
- 206010039085 Rhinitis allergic Diseases 0.000 title abstract 2
- 201000010105 allergic rhinitis Diseases 0.000 title abstract 2
- 229960001508 levocetirizine Drugs 0.000 title abstract 2
- 230000002085 persistent effect Effects 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Ophthalmology & Optometry (AREA)
Abstract
L'invention concerne l'utilisation pharmaceutique de la levocétirizine pour le traitement de la rhinite allergique persistante.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02080064 | 2002-12-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27530A1 true MA27530A1 (fr) | 2005-09-01 |
Family
ID=32405747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA28297A MA27530A1 (fr) | 2002-12-03 | 2005-05-26 | Utilisation de la levocetirizine pour le traitement de la rhinite allergique persistante. |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20060247258A1 (fr) |
| EP (1) | EP1569650B1 (fr) |
| JP (1) | JP2006509773A (fr) |
| KR (1) | KR20050085298A (fr) |
| CN (1) | CN1713912A (fr) |
| AT (1) | ATE396730T1 (fr) |
| AU (1) | AU2003238399B2 (fr) |
| BR (1) | BR0316823A (fr) |
| CA (1) | CA2506965A1 (fr) |
| CR (1) | CR7835A (fr) |
| CY (1) | CY1108191T1 (fr) |
| DE (1) | DE60321377D1 (fr) |
| DK (1) | DK1569650T3 (fr) |
| ES (1) | ES2304514T3 (fr) |
| HR (1) | HRP20050497B1 (fr) |
| MA (1) | MA27530A1 (fr) |
| MX (1) | MXPA05005795A (fr) |
| NO (1) | NO20053247D0 (fr) |
| NZ (1) | NZ540415A (fr) |
| PL (1) | PL377470A1 (fr) |
| PT (1) | PT1569650E (fr) |
| RU (1) | RU2005121130A (fr) |
| SI (1) | SI1569650T1 (fr) |
| TN (1) | TNSN05154A1 (fr) |
| WO (1) | WO2004050094A1 (fr) |
| ZA (1) | ZA200503703B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20060484A1 (es) | 2004-07-14 | 2006-07-06 | Ucb Farchim Sa | Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina |
| US8263581B2 (en) | 2009-07-03 | 2012-09-11 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
| US8513259B2 (en) | 2009-07-03 | 2013-08-20 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0950412A3 (fr) * | 1992-09-24 | 2001-05-16 | Sepracor, Inc. | Compositions pour traiter des affections allergiques à l'aide de (-) cétirizine |
| US20030236275A1 (en) * | 2002-06-20 | 2003-12-25 | Schering Corporation | Treatment methods of nasal congestion and nasal obstruction |
-
2003
- 2003-05-26 SI SI200331246T patent/SI1569650T1/sl unknown
- 2003-05-26 ZA ZA200503703A patent/ZA200503703B/xx unknown
- 2003-05-26 CA CA002506965A patent/CA2506965A1/fr not_active Abandoned
- 2003-05-26 RU RU2005121130/14A patent/RU2005121130A/ru unknown
- 2003-05-26 US US10/536,939 patent/US20060247258A1/en not_active Abandoned
- 2003-05-26 AU AU2003238399A patent/AU2003238399B2/en not_active Ceased
- 2003-05-26 PL PL377470A patent/PL377470A1/pl not_active Application Discontinuation
- 2003-05-26 DK DK03732466T patent/DK1569650T3/da active
- 2003-05-26 PT PT03732466T patent/PT1569650E/pt unknown
- 2003-05-26 MX MXPA05005795A patent/MXPA05005795A/es active IP Right Grant
- 2003-05-26 WO PCT/EP2003/005491 patent/WO2004050094A1/fr active IP Right Grant
- 2003-05-26 NZ NZ540415A patent/NZ540415A/en not_active IP Right Cessation
- 2003-05-26 ES ES03732466T patent/ES2304514T3/es not_active Expired - Lifetime
- 2003-05-26 JP JP2004556076A patent/JP2006509773A/ja active Pending
- 2003-05-26 BR BR0316823-9A patent/BR0316823A/pt not_active IP Right Cessation
- 2003-05-26 AT AT03732466T patent/ATE396730T1/de not_active IP Right Cessation
- 2003-05-26 KR KR1020057009991A patent/KR20050085298A/ko not_active Application Discontinuation
- 2003-05-26 EP EP03732466A patent/EP1569650B1/fr not_active Revoked
- 2003-05-26 CN CNA038255448A patent/CN1713912A/zh active Pending
- 2003-05-26 DE DE60321377T patent/DE60321377D1/de not_active Revoked
-
2005
- 2005-05-11 CR CR7835A patent/CR7835A/es unknown
- 2005-05-26 MA MA28297A patent/MA27530A1/fr unknown
- 2005-06-02 TN TNP2005000154A patent/TNSN05154A1/en unknown
- 2005-06-02 HR HR20050497A patent/HRP20050497B1/xx not_active IP Right Cessation
- 2005-07-01 NO NO20053247A patent/NO20053247D0/no unknown
-
2008
- 2008-07-11 CY CY20081100732T patent/CY1108191T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1108191T1 (el) | 2012-05-23 |
| JP2006509773A (ja) | 2006-03-23 |
| ES2304514T3 (es) | 2008-10-16 |
| HRP20050497A2 (en) | 2005-12-31 |
| DK1569650T3 (da) | 2008-06-30 |
| AU2003238399B2 (en) | 2009-05-07 |
| DE60321377D1 (de) | 2008-07-10 |
| WO2004050094A1 (fr) | 2004-06-17 |
| NO20053247L (no) | 2005-07-01 |
| NZ540415A (en) | 2008-06-30 |
| KR20050085298A (ko) | 2005-08-29 |
| MXPA05005795A (es) | 2005-08-16 |
| ZA200503703B (en) | 2006-10-25 |
| RU2005121130A (ru) | 2005-12-10 |
| EP1569650B1 (fr) | 2008-05-28 |
| EP1569650A1 (fr) | 2005-09-07 |
| SI1569650T1 (sl) | 2008-08-31 |
| US20060247258A1 (en) | 2006-11-02 |
| PL377470A1 (pl) | 2006-02-06 |
| CA2506965A1 (fr) | 2004-06-17 |
| CR7835A (es) | 2008-12-01 |
| AU2003238399A1 (en) | 2004-06-23 |
| ATE396730T1 (de) | 2008-06-15 |
| PT1569650E (pt) | 2008-06-26 |
| CN1713912A (zh) | 2005-12-28 |
| BR0316823A (pt) | 2005-10-18 |
| HRP20050497B1 (en) | 2008-10-31 |
| NO20053247D0 (no) | 2005-07-01 |
| TNSN05154A1 (en) | 2007-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA28289A1 (fr) | Immunoglobulines | |
| MA27334A1 (fr) | Utilisation d'inhibiteurs de l'ikb kinase dans le traitement de la douleur | |
| FR13C0060I2 (fr) | Omega-carboxyaryldiphenyluree fluoro-subtituee pour le traitement et la prevention de maladies et d'etats pathologiques | |
| FR2854074B1 (fr) | Utilisation de l'ivermectine pour le traitement de desordres dermatologiques | |
| MA29169B1 (fr) | Formulations intraveineuses d'inhibiteurs de la pde-5 | |
| EA200201247A1 (ru) | Соединения для лечения болезни альцгеймера | |
| DK1465626T3 (da) | Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf | |
| TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| MEP42808A (en) | Use of flibanserin in the treatment of sexual disorders | |
| MA30041B1 (fr) | Immunoglobulines | |
| TNSN02022A1 (fr) | Triazolopyridines anti-inflammatoires nouvelles, et compositions les contenant | |
| DE60204951D1 (de) | Ccr5 antagonisten verwendbar für die behandlung von aids | |
| ATE502642T1 (de) | Kombinationen für die behandlung von immun- entzündlichen erkrankungen | |
| DE60204466D1 (de) | Integrinhemmer zur behandlung von augenkrankheiten | |
| SE9901077D0 (sv) | Novel use | |
| NO20025405D0 (no) | Modulatorer for TNF-alfa-signalisering | |
| MA29625B1 (fr) | Immunoglobulines | |
| ATE271861T1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| MA27530A1 (fr) | Utilisation de la levocetirizine pour le traitement de la rhinite allergique persistante. | |
| FR2800614B1 (fr) | Composition pour le traitement des infections des voies respiratoires | |
| ATE341323T1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
| DE60330233D1 (de) | Arsentherapie zur behandlung von autoimmunerkrankungen | |
| FR2843015B1 (fr) | Implant pour le traitement de la presbytie | |
| FR2862537B1 (fr) | Utilisation du fepradinol pour la preparation d'une composition pharmaceutique pour le traitement de la rosacee | |
| FR2829363B1 (fr) | Utilisations d'inhibiteurs de l'acetohydroxyacide isomeroreductase pour le traitement des maladies fongiques des cultures |